Free tool
Drug Trial Radar: Pain and anesthesia
Last checked: Nov 20, 2026Latest source record: Sep 28, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
4
Recruiting, industry sponsors, Pain and anesthesia, Phase 4 (post-approval)
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed261
4 trials
Showing 1 to 4, recently updated first.
Jiangsu HengRui Medicine Co., Ltd.Industry
NCT06344091 · 232 participants (planned) · Start May 21, 2024 · Primary completion May 2027
Drug: Bupivacaine Liposome Injection · For: Local Analgesia Via Infiltration
Sites: Guangzhou, China
Novartis PharmaceuticalsNovartis (NVS)
NCT07489573 · 36 participants (planned) · Start Jun 1, 2026 · Primary completion Sep 25, 2029
Drug: Secukinumab · For: Hidradenitis Suppurativa (HS)
Sites: Guangzhou, China; Shijiazhuang, China; Chengdu, China · 10 sites in all
Biotechnology Institute IMASDIndustry
NCT06715085 · 48 participants (planned) · Start Jan 23, 2025 · Primary completion Feb 1, 2026
Drug: Plasma Rich in Growth Factors (PRGF); Corticosteroid solution (Celestone Cronodose suspension for injection) in saline solution. · For: Diseases [C] - Musculoskeletal Diseases [C05
Sites: Vitoria-Gasteiz, Spain
Haisco Pharmaceutical Group Co., Ltd.Industry
NCT06740201 · 40 participants (planned) · Start Jan 6, 2025 · Primary completion Mar 30, 2025
Drug: Cipepofol · For: Anesthesia
Sites: Chengde, China; Shijiazhuang, China
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.